HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BAL9611

a farnesyl-transferase inhibitor; structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - BAL9611: 1

Experts

1.	Boggi, U: 1 article (06/2001)
2.	Caputo, S: 1 article (06/2001)
3.	Danesi, R: 1 article (06/2001)
4.	Del Tacca, M: 1 article (06/2001)
5.	Di Paolo, A: 1 article (06/2001)
6.	Lastella, M: 1 article (06/2001)
7.	Macchia, M: 1 article (06/2001)
8.	Marchetti, A: 1 article (06/2001)
9.	Mosca, F: 1 article (06/2001)

Related Diseases

1.

Colonic Neoplasms (Colon Cancer)

06/01/2001 - "Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells."
06/01/2001 - "Therefore, the combined effect of BAL9611, a novel inhibitor of geranylgeranylation, and manumycin, a farnesyl-transferase inhibitor, was evaluated on the SW620 human colon cancer cell line which harbours a mutated K-ras gene. "

Related Drugs and Biologics

1.	Transferases
2.	manumycin